#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalopathy neonatal Neuropathy peripheral Glycogen storage disease type II Ewing's sarcoma metastatic Skin cancer Shprintzen-Goldberg syndrome Mucous membrane pemphigoid Blood iron increased Mucopolysaccharidosis I Kawasaki's disease Cutaneous calcification Fatty acid oxidation disorder Phenylketonuria Non-Hodgkin's lymphoma refractory T-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Trials in Disease IgA nephropathy – Treatment Marginal zone lymphoma refractory – Diagnostics Indolent systemic mastocytosis – Diagnostics Acute respiratory distress syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Mantle cell lymphoma stage IV – Trials in Disease Haemophilia – Basic Information Cerebral arteriovenous malformation haemorrhagic – Treatment Medulloblastoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    64CU-PSMA I&T VANADIUM OXIDE SULFATE Inavolisib Mps-215 Tusamitamab Ravtansine Tiratricol Tozinameran Lerodalcibep Doxycycline Latanoprost Ketoprofen Anifrolumab S230815-2 Dersimelagon Phosphate Timolol Nipocalimab Golexanolone Deucravacitinib Orlistat GSK5764227 More therapies…

    Learn about Your Condition

    Procedural pain External cephalic version Dupuytren's contracture Gouty arthritis Infective uveitis Dyspepsia Partial lipodystrophy Persistent depressive disorder Angiosarcoma metastatic Basal cell carcinoma Obsessive-compulsive disorder Arteriovenous graft thrombosis Conjunctivitis Acute lymphocytic leukaemia Arthralgia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dry age-related macular degeneration

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Dry age-related macular degeneration
    France

  • A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ADX-038
    • Sodium Chloride
    Germany Italy Portugal Spain

  • Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • ANX007
    Austria Czechia France Germany Hungary Italy +3

  • Study on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Pegcetacoplan
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on Elamipretide for Patients with Dry Age-Related Macular Degeneration (Dry AMD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    Czechia Germany Hungary Italy Spain

  • Long-Term Safety Study of GT005 for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration Previously Treated in a Gyroscope Study

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Gt005
    France Germany Poland Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!